Inicio › Cáncer del colon y del recto › Ohio › Columbus
Ensayos clínicos de Cáncer del colon y del recto en Columbus, OH
24 estudios para Cáncer del colon y del recto buscan participantes en centros de Columbus y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
ReclutandoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- y 8 más
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ReclutandoFase 1
- ALX Center 10, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- The Ohio State University Comprehensive Cancer Center, Columbus
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ReclutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
ReclutandoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
ReclutandoFase 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Columbus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
ReclutandoFase 3
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- Ohio Health, Columbus
- Zangmeister Center, Columbus
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
ReclutandoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
ReclutandoFase 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
ReclutandoFase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
ReclutandoFase 4
- Zangmeister Cancer Center, Columbus
Lead-212 PSV359 Therapy for Patients With Solid Tumors
ReclutandoFase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ReclutandoFase 1
- Ohio State University, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Memorial Hospital, Marysville · A 27 mi de distancia
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
ReclutandoEstudio observacional
- The Mark H Zangmeister Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
ReclutandoSe aceptan voluntarios sanos
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
ReclutandoEstudio observacional
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Más información sobre Cáncer del colon y del recto en MedlinePlus
Ensayos de Cáncer del colon y del recto en otras ciudades
- Houston, TX102 estudios
- New York City, NY78 estudios
- Nashville, TN69 estudios
- Boston, MA63 estudios
- Los Angeles, CA59 estudios
- Arlington, VA52 estudios
- St. Louis, MO50 estudios
- San Antonio, TX46 estudios
- Philadelphia, PA44 estudios
- Grand Rapids, MI40 estudios
- Baldwin Park, CA37 estudios
- Chicago, IL34 estudios
Otros estudios en Columbus
- Cáncer de pulmón de células no pequeñas57 estudios
- Cáncer de seno40 estudios
- Cáncer de ovario39 estudios
- Cáncer (todos los tipos)38 estudios
- Cáncer de pulmón37 estudios
- Leucemia mielógena aguda35 estudios
- Leucemia linfocítica crónica28 estudios
- Cáncer metastásico27 estudios
- Cáncer de endometrio25 estudios
- Cáncer de próstata24 estudios
- Mieloma múltiple24 estudios
- Melanoma21 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.